|
66 |
Shitara, K. (12764260600); Fleitas, T. (24070244600); Kawakami, H. (53663802900); Curigliano, G. (57221578995); Narita, Y. (58906540500); Wang, F. (55556809000); Wardhani, S.O. (57193196381); Basade, M. (8088436500); Rha, S.Y. (57968356600); Wan Zamaniah, W.I. (57197752505); Sacdalan, D.L. (57193522866); Ng, M. (56693812000); Yeh, K.H. (58911030700); Sunpaweravong, P. (6508227376); Sirachainan, E. (6602792356); Chen, M.-H. (58911030800); Yong, W.P. (58910827500); Peneyra, J.L. (58910632700); Ibt |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer |
ESMO Open |
0 |
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Mainland China, Guangzhou, China; Department of Internal Medicine Division of Medical Hematology-Oncology, Brawijaya University, Dr. Saiful Anwar General Hospital Malang, East Java, Indonesia; Department of Medical Oncology, Jaslok Hospital and Breach Candy Hospital, Mumbai, India; Department of Internal Medicine, Yonsei University College of Medicine, Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea; Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Division of Medical Oncology, Department of Medicine, University of the Philippines, The Philippines, Manila, Philippines; Department of GI Oncology, National Cancer Centre Singapore, Singapore, Singapore; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore; St. Peregrine Oncology Unit, San Juan de Dios Hospital, The Philippines, Pasay City, Philippines; Institute of Radiotherapy and Oncology, General Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea; Department of Medical Oncology, AIG Hospital, Hyderabad, India; Division of Gastroenterology, Pancreatobiliary Oncology and Digestive Endoscopy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Oncology, University of Tongji, Shanghai East Hospital, Mainland China, Shanghai, China; Section of Medical Oncology, Department of Internal Medicine, Southern Philippines Medical Center ESM, The Philippines, Davao City, Philippines; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; ESMO, Lugano, Switzerland; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan; Department of Oncology, Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom |
|
|
Elsevier B.V. |
Q1 |
|
|
